Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity

The anatomic response to intravitreal bevacizumab injection in three patients with aggressive, posterior retinopathy of prematurity is described. In all cases, the worse eye was treated with a single intravitreal injection of 0.75 mg of bevacizumab as monotherapy or complementary to laser therapy. I...

Full description

Bibliographic Details
Main Author: Travassos, A (author)
Other Authors: Teixeira, S (author), Ferreira, P (author), Regadas, I (author), Travassos, AS (author), Esperancinha, F (author), Prieto, I (author), Pires, G (author), van Velze, R (author), Valido, A (author), Machado, MC (author)
Format: article
Language:eng
Published: 2013
Subjects:
Retinopathy of prematurity
Intravitreal bevacizumab
Newborn
Online Access:http://hdl.handle.net/10400.10/852
Country:Portugal
Oai:oai:repositorio.hff.min-saude.pt:10400.10/852

Internet

http://hdl.handle.net/10400.10/852

Similar Items